Failed 2025

    Ÿnsect

    Novel-food category creation requires 10-20 year time horizons and government offtake. If your CapEx is denominated in fish-meal alternative pricing, you need fish-meal-alternative demand to actually exist.

    TL;DR — Failure Post-Mortem

    Ÿnsect was a AgTech / Insect Farming startup founded in 2011 in France. It raised $600M+ before collapsing in 2025 — 14 years of runway burned. IdeaProof's AI Failure Score: 54/100, driven by insect protein market demand never materialized at scale; capex exceeded revenues by 10x. The shutdown affected employees, investors, and the broader AgTech / Insect Farming ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.

    Why did Ÿnsect fail?

    Ÿnsect failed in 2025 after 14 years of operation, losing $600M+ in raised capital. The root cause was insect protein market demand never materialized at scale; capex exceeded revenues by 10x. Key lesson: Novel-food category creation requires 10-20 year time horizons and government offtake. If your CapEx is denominated in fish-meal alternative pricing, you need fish-meal-alternative demand to actually exist.

    Verifiable facts
    Sourced
    Founded → Closed

    2011 → 2025

    Funding Raised

    $600M+

    Industry

    AgTech / Insect Farming

    Country

    France

    IdeaProof AI Failure Score

    54/100
    Market Fit Risk
    55
    Burn Rate Risk
    60
    Founder Risk
    45

    What Happened: The Timeline

    🚀

    2011

    Ÿnsect founded in France. Positioned in agtech / insect farming.

    💰

    2011-2013

    Raises $600M+ from Astanor Ventures, Idinvest, Robert Downey Jr., FootPrint Coalition, BPI France.

    ⚠️

    2024

    Warning signs emerge: 10x capex overhang vs revenue.

    💀

    2025

    Shutdown announced. Root cause: insect protein market demand never materialized at scale; capex exceeded revenues by 10x.

    Root Causes

    Ÿnsect (pronounced 'insect') was the flagship European insect-protein startup, founded in 2011 in Paris by Antoine Hubert to farm mealworms at industrial scale for pet food, aquaculture and eventually human consumption. It raised over $600M — the largest ever for a European agtech — from Astanor, Idinvest, Robert Downey Jr.'s FootPrint Coalition and BPI France, and broke ground on the world's largest vertical insect farm in Amiens. In December 2025 TechCrunch documented the wind-down: the Amiens facility ran at a fraction of nameplate capacity, aquaculture buyers preferred cheaper fish meal even at ESG-conscious European premiums, and the human-food thesis was blocked by EU novel-food regulatory delays. The company entered court-supervised restructuring, sold assets, and became the definitive cautionary tale for agtech at scale.

    Causal Chain

    Derived · heuristic

    This is our reading of the causal chain — separated from the verifiable facts above. Timeline dates, funding numbers and filings are facts (see methodology); root / proximate / terminal attribution is judgement based on public evidence.

    Root cause

    A combination of demand-side, execution, and capital-market pressures that this record documents without isolating a single dominant driver.

    Contributing factors
    • 10x CapEx overhang vs revenue
    • Aquaculture buyers didn't pay ESG premium
    • EU novel-food regulatory delays
    • Fish meal price never rose to make insect protein competitive
    Proximate cause

    2024: Warning signs emerge: 10x capex overhang vs revenue.

    Terminal event

    2025: Shutdown announced. Root cause: insect protein market demand never materialized at scale; capex exceeded revenues by 10x.

    Base rates

    External sources

    A single failure is an anecdote. These base rates give you the denominator — how common this outcome is across all startups matching Ÿnsect's profile. Sources are third-party; we do not restate them as our own claims.

    ~90%
    all

    of startups ultimately fail — including ~10% that fail in the first year and the rest across the following decade.

    Startup Genome / CB Insights aggregate (2024)
    ~35%
    all

    of new US employer businesses survive past their 10th year (Bureau of Labor Statistics BED series).

    US Bureau of Labor Statistics — BED (2024)
    ~35%
    stage

    of Series A rounds ever graduate to Series B; the rest run out of runway or pivot without a follow-on.

    CB Insights Venture Capital Funnel (2023)

    Key Lessons Learned

    1. 10x CapEx overhang vs revenue

    10x CapEx overhang vs revenue — a recurring pattern across agtech / insect farming failures. Validate this risk before you scale.

    2. Aquaculture buyers didn't pay ESG premium

    Aquaculture buyers didn't pay ESG premium — a recurring pattern across agtech / insect farming failures. Validate this risk before you scale.

    3. EU novel-food regulatory delays

    EU novel-food regulatory delays — a recurring pattern across agtech / insect farming failures. Validate this risk before you scale.

    Frequently Asked Questions

    Sources & Confidence

    Every data point is tagged with its source type and our confidence in it. How we grade sources.

    Additional references

    Could This Failure Have Been Prevented?

    IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Ÿnsect.

    Spotted a factual error?

    Approved corrections are published in the public changelog with attribution.

    After Ÿnsect: hubs, comparisons and deep dives

    Compare the validation, funding and go-to-market choices that separate survivors from failures like Ÿnsect.